Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032
The Europe specialty generics market size reached US$ 19.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.7 Billion by 2024-2032, exhibiting a growth rate (CAGR) of 7.7% during 2032. The increasing prevalence of chronic diseases, rising demand for affordable medicines, and implementation of favorable regulatory guidelines are some of the key factors driving the market.
Specialty generics refer to complex, difficult-to-produce medications that are created as a lower-cost alternative to brand-name drugs. These drugs are generally used to treat chronic conditions and diseases that require long-term therapy, such as cancer, autoimmune disorders, and human immunodeficiency virus (HIV). Specialty generics should be identical in both chemical structure and therapeutic effect to the brand-name drug it is intended to replace. The production of these drugs requires a high level of expertise and sophisticated technology to ensure quality control and consistency. Specialty generics are composed of the same active ingredient as the brand-name drug but may differ in other components, such as excipients, fillers, and binders. Currently, there are two types of product variants, such as biosimilars and complex generics. Biosimilars are drugs that are similar to biologic drugs, whereas complex generics are generic versions of drugs that are chemically and structurally complex.
Europe Specialty Generics Market Trends:
Europe specialty generics market is primarily boosted by the growing geriatric population, increasing prevalence of chronic diseases, and the rising demand for affordable medicines. Additionally, the implementation of favorable regulatory guidelines by the European Medicines Agency (EMA) and the increasing adoption of biosimilars are boosting the market growth. Apart from this, several manufacturers are developing cost-effective biosimilars that offer similar efficacy and safety as branded drugs, which is providing an impetus to the market growth. Furthermore, burgeoning investments by leading pharmaceutical companies in research and development (R&D) activities to develop innovative drugs and the rising awareness about the benefits of specialty generic drugs are providing a considerable thrust to the market growth. Moreover, the integration of robotics and artificial intelligence (AI) in the manufacturing process to enable automation, reduce manual labor, maintain product quality, and enhance overall efficiency is positively influencing the market growth. Besides this, the increasing focus on expanding the product portfolio by key players, the growing demand for personalized medicine, the surging adoption of e-prescriptions, the increasing consumer awareness and acceptance of specialty generics, rising healthcare expenditure, extensive research and development (R&D) activities, and the development of novel drug delivery technologies are accelerating the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on route of administration, indication and distribution channel.
Route of Administration Insights:
Injectables
Oral
Others
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the route of administration. This includes injectables, oral, and others. According to the report, the injectables segment dominates the market.
Indication Insights:
Oncology
Autoimmune Diseases
Infectious Diseases
Others
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the indication. This includes oncology, autoimmune diseases, infectious diseases, and others. According to the report, the oncology segment dominates the market.
Distributional Channel Insights:
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the distributional channel. This includes retail pharmacies, specialty pharmacies, and hospital pharmacies. According to the report, the retail pharmacies segment holds the largest market share.
Regional Insights:
Italy
Germany
France
United Kingdom
Spain
Rest of Europe
The report has also provided a comprehensive analysis of all the major regional markets, which include. Italy, Germany, France, the United Kingdom, Spain, and the Rest of Europe. As per the report, Italy dominates the market. Some of the factors accelerating the Italy specialty generics market include the surging awareness regarding the advantages of specialty generics, inflating consumer per capita income, and the growing prevalence of chronic diseases.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the Europe specialty generics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. The leading players in the European specialty generics industry have also been examined in the report.
Key Questions Answered in This Report
1. What was the size of the Europe specialty generics market in 2023?
2. What is the expected growth rate of the Europe specialty generics market during 2024-2032?
3. What are the key factors driving the Europe specialty generics market?
4. What has been the impact of COVID-19 on the Europe specialty generics market?
5. What is the breakup of the Europe specialty generics market based on the route of administration?
6. What is the breakup of the Europe specialty generics market based on the indication?
7. What is the breakup of the Europe specialty generics market based on the distribution channel?
8. What are the key regions in the Europe specialty generics market?
Specialty generics refer to complex, difficult-to-produce medications that are created as a lower-cost alternative to brand-name drugs. These drugs are generally used to treat chronic conditions and diseases that require long-term therapy, such as cancer, autoimmune disorders, and human immunodeficiency virus (HIV). Specialty generics should be identical in both chemical structure and therapeutic effect to the brand-name drug it is intended to replace. The production of these drugs requires a high level of expertise and sophisticated technology to ensure quality control and consistency. Specialty generics are composed of the same active ingredient as the brand-name drug but may differ in other components, such as excipients, fillers, and binders. Currently, there are two types of product variants, such as biosimilars and complex generics. Biosimilars are drugs that are similar to biologic drugs, whereas complex generics are generic versions of drugs that are chemically and structurally complex.
Europe Specialty Generics Market Trends:
Europe specialty generics market is primarily boosted by the growing geriatric population, increasing prevalence of chronic diseases, and the rising demand for affordable medicines. Additionally, the implementation of favorable regulatory guidelines by the European Medicines Agency (EMA) and the increasing adoption of biosimilars are boosting the market growth. Apart from this, several manufacturers are developing cost-effective biosimilars that offer similar efficacy and safety as branded drugs, which is providing an impetus to the market growth. Furthermore, burgeoning investments by leading pharmaceutical companies in research and development (R&D) activities to develop innovative drugs and the rising awareness about the benefits of specialty generic drugs are providing a considerable thrust to the market growth. Moreover, the integration of robotics and artificial intelligence (AI) in the manufacturing process to enable automation, reduce manual labor, maintain product quality, and enhance overall efficiency is positively influencing the market growth. Besides this, the increasing focus on expanding the product portfolio by key players, the growing demand for personalized medicine, the surging adoption of e-prescriptions, the increasing consumer awareness and acceptance of specialty generics, rising healthcare expenditure, extensive research and development (R&D) activities, and the development of novel drug delivery technologies are accelerating the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on route of administration, indication and distribution channel.
Route of Administration Insights:
Injectables
Oral
Others
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the route of administration. This includes injectables, oral, and others. According to the report, the injectables segment dominates the market.
Indication Insights:
Oncology
Autoimmune Diseases
Infectious Diseases
Others
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the indication. This includes oncology, autoimmune diseases, infectious diseases, and others. According to the report, the oncology segment dominates the market.
Distributional Channel Insights:
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the distributional channel. This includes retail pharmacies, specialty pharmacies, and hospital pharmacies. According to the report, the retail pharmacies segment holds the largest market share.
Regional Insights:
Italy
Germany
France
United Kingdom
Spain
Rest of Europe
The report has also provided a comprehensive analysis of all the major regional markets, which include. Italy, Germany, France, the United Kingdom, Spain, and the Rest of Europe. As per the report, Italy dominates the market. Some of the factors accelerating the Italy specialty generics market include the surging awareness regarding the advantages of specialty generics, inflating consumer per capita income, and the growing prevalence of chronic diseases.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the Europe specialty generics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. The leading players in the European specialty generics industry have also been examined in the report.
Key Questions Answered in This Report
1. What was the size of the Europe specialty generics market in 2023?
2. What is the expected growth rate of the Europe specialty generics market during 2024-2032?
3. What are the key factors driving the Europe specialty generics market?
4. What has been the impact of COVID-19 on the Europe specialty generics market?
5. What is the breakup of the Europe specialty generics market based on the route of administration?
6. What is the breakup of the Europe specialty generics market based on the indication?
7. What is the breakup of the Europe specialty generics market based on the distribution channel?
8. What are the key regions in the Europe specialty generics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 EUROPE SPECIALTY GENERICS MARKET: INTRODUCTION
5 WHY ARE SPECIALTY GENERICS SO LUCRATIVE?
6 EUROPE SPECIALTY GENERICS MARKET
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY INDICATION
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 Germany
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 France
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 United Kingdom
10.3.1 Market Overview
10.3.2 Market Performance
10.4 Spain
10.4.1 Market Performance
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 COMPETITIVE LANDSCAPE
11.1 Market Structure
11.2 Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 EUROPE SPECIALTY GENERICS MARKET: INTRODUCTION
5 WHY ARE SPECIALTY GENERICS SO LUCRATIVE?
6 EUROPE SPECIALTY GENERICS MARKET
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY INDICATION
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 Germany
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 France
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 United Kingdom
10.3.1 Market Overview
10.3.2 Market Performance
10.4 Spain
10.4.1 Market Performance
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 COMPETITIVE LANDSCAPE
11.1 Market Structure
11.2 Key Players
LIST OF TABLES
Table 1: Europe: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 2: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2024-2032
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2024-2032
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2024-2032
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2024-2032
Table 6: Europe: Specialty Generics Market Structure
Table 7: Europe: Specialty Generics Market: Key Players
Table 1: Europe: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 2: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2024-2032
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2024-2032
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2024-2032
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2024-2032
Table 6: Europe: Specialty Generics Market Structure
Table 7: Europe: Specialty Generics Market: Key Players
LIST OF FIGURES
Figure 1: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2018-2023
Figure 2: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2023
Figure 3: Europe: Specialty Generics Market: Breakup by Indication (in %), 2023
Figure 4: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2023
Figure 5: Europe: Specialty Generics Market: Breakup by Region (in %), 2023
Figure 6: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 7: Europe: Specialty Generics Industry: SWOT Analysis
Figure 8: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 9: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2018 & 2023
Figure 11: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 12: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2018 & 2023
Figure 13: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 14: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2018 & 2023
Figure 15: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 16: Europe: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2018 & 2023
Figure 17: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 18: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2018 & 2023
Figure 19: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 20: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2018 & 2023
Figure 21: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 22: Europe: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2018 & 2023
Figure 23: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 24: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Billion US$), 2018 & 2023
Figure 25: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Billion US$), 2024-2032
Figure 26: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Billion US$), 2018 & 2023
Figure 27: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Billion US$), 2024-2032
Figure 28: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Billion US$), 2018 & 2023
Figure 29: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Billion US$), 2024-2032
Figure 30: Germany: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 31: Germany: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 32: United Kingdom: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 33: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 34: France: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 35: France: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 36: Italy: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 37: Italy: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 38: Spain: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 39: Spain: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 40: Rest of Europe: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 41: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 1: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2018-2023
Figure 2: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2023
Figure 3: Europe: Specialty Generics Market: Breakup by Indication (in %), 2023
Figure 4: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2023
Figure 5: Europe: Specialty Generics Market: Breakup by Region (in %), 2023
Figure 6: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 7: Europe: Specialty Generics Industry: SWOT Analysis
Figure 8: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 9: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2018 & 2023
Figure 11: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 12: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2018 & 2023
Figure 13: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 14: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2018 & 2023
Figure 15: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 16: Europe: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2018 & 2023
Figure 17: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 18: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2018 & 2023
Figure 19: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 20: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2018 & 2023
Figure 21: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 22: Europe: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2018 & 2023
Figure 23: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 24: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Billion US$), 2018 & 2023
Figure 25: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Billion US$), 2024-2032
Figure 26: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Billion US$), 2018 & 2023
Figure 27: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Billion US$), 2024-2032
Figure 28: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Billion US$), 2018 & 2023
Figure 29: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Billion US$), 2024-2032
Figure 30: Germany: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 31: Germany: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 32: United Kingdom: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 33: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 34: France: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 35: France: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 36: Italy: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 37: Italy: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 38: Spain: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 39: Spain: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 40: Rest of Europe: Specialty Generics Market: Sales Value (in Billion US$), 2018 & 2023
Figure 41: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
